Affimed
AFMD
$2.73
Share price
-1.80%
Change (1 day)
-67.69%
Change (1 year)
Categories
Market capitalization of Affimed (AFMD)
Market cap: $0.40 Billion
As of June 2022 Affimed has a market cap of $0.40 Billion. This makes Affimed the world's 5110th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Affimed from 2014 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $0.40 B | -38.81% |
| 2021 | $0.66 B | 15.8% |
| 2020 | $0.57 B | 173.33% |
| 2019 | $0.20 B | 7.61% |
| 2018 | $0.19 B | 234.34% |
| 2017 | $0.05 B | -3% |
| 2016 | $0.05 B | -74.72% |
| 2015 | $0.23 B | 59.25% |
| 2014 | $0.14 B |
End of Day market cap according to different sources
On Jun 28th, 2022 the market cap of Affimed was reported to be:
$0.41 Billion
$0.41 Billion
$0.33 Billion
$0.34 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | $9.11 B | 2,136.96% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $0.07 B | -81.15% | 🇺🇸 USA |
 Agenus
AGEN | $0.62 B | 52.11% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.01 B | -97.38% | 🇺🇸 USA |